- Home
- OSUR vs CDTX Comparison
OSUR vs CDTX Comparison
Compare OSUR & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CDTX
- Stock Information
- Founded
- OSUR 2000
- CDTX 2012
- Country
- OSUR United States
- CDTX United States
- Employees
- OSUR N/A
- CDTX N/A
- Industry
- OSUR Medical/Dental Instruments
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSUR Health Care
- CDTX Health Care
- Exchange
- OSUR Nasdaq
- CDTX Nasdaq
- Market Cap
- OSUR 248.3M
- CDTX 259.0M
- IPO Year
- OSUR 1986
- CDTX 2015
- Fundamental
- Price
- OSUR $3.23
- CDTX $17.82
- Analyst Decision
- OSUR Hold
- CDTX Strong Buy
- Analyst Count
- OSUR 2
- CDTX 8
- Target Price
- OSUR $5.50
- CDTX $38.00
- AVG Volume (30 Days)
- OSUR 682.8K
- CDTX 156.0K
- Earning Date
- OSUR 05-07-2025
- CDTX 05-14-2025
- Dividend Yield
- OSUR N/A
- CDTX N/A
- EPS Growth
- OSUR N/A
- CDTX N/A
- EPS
- OSUR N/A
- CDTX N/A
- Revenue
- OSUR $185,827,000.00
- CDTX $1,275,000.00
- Revenue This Year
- OSUR N/A
- CDTX N/A
- Revenue Next Year
- OSUR $7.46
- CDTX N/A
- P/E Ratio
- OSUR N/A
- CDTX N/A
- Revenue Growth
- OSUR N/A
- CDTX N/A
- 52 Week Low
- OSUR $2.69
- CDTX $10.00
- 52 Week High
- OSUR $6.35
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- OSUR 40.59
- CDTX 33.85
- Support Level
- OSUR $3.34
- CDTX $19.83
- Resistance Level
- OSUR $3.38
- CDTX $23.76
- Average True Range (ATR)
- OSUR 0.15
- CDTX 1.58
- MACD
- OSUR -0.01
- CDTX -0.53
- Stochastic Oscillator
- OSUR 0.50
- CDTX 5.11
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.